Outlook Therapeutics
OTLK
OTLK
64 hedge funds and large institutions have $62.7M invested in Outlook Therapeutics in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 7 closing their positions.
Holders
64
Holders Change
+8
Holders Change %
+14.29%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
24
Reduced
11
Closed
7
Calls
$99K
Puts
$7K
Net Calls
+$92K
Net Calls Change
+$92K
Top Buyers
1 |
ACM
1
Altium Capital Management
New York
|
$3.7M |
2 |
BFM
2
Boothbay Fund Management
New York
|
$1.85M |
3 |
GPP
3
Great Point Partners
Greenwich,
Connecticut
|
$12.6M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$4.04M |
5 |
5
BlackRock
New York
|
$4.9M |